Brief: Propanc Biopharma Implements Reverse Stock Split To Support Continued Nasdaq Listing And Growth Plans
14/05/2026 03:00
May 13 (Reuters) - Propanc Biopharma Inc PPCB.O: PROPANC BIOPHARMA IMPLEMENTS REVERSE STOCK SPLIT TO SUPPORT CONTINUED NASDAQ LISTING AND GROWTH PLANS PROPANC BIOPHARMA INC - APPROVES 1-FOR-25 REVERSE STOCK SPLIT EFFECTIVE MAY 18, 2026 Source text: ID:nGNX38YJxk Further company coverage: PPCB.O ((Reuters.Briefs@thomsonreuters.com;))